Perforomist: FDA Approved Treatment for COPD

Chronic Obstructive Pulmonary Disease is a complex condition that renders the patient unable to perform many activities of daily living without the use of oxygen. For many COPD patients, finding the right blend of prescription medications can be equally challenging due to the potential side effects of many medications.

As a chronic and progressive lung disorder, Chronic Obstructive Pulmonary Disease is a leading cause of death among aging Americans. With well over 10 million individuals, in the United States alone, suffering from COPD, there is a great movement to find options in nebulizing therapy.

With the FDA approval of the Perforomist Inhaler, manufactured by Dey, L.P., patients who suffer from COPD are provided one additional option in the fight against pulmonary obstruction and bronchoconstriction so commonly associated with COPD.

Dosing of the Perforomist Inhaler, in the COPD patient, is quite simple with dosing recommended once in the morning and once in the evening through the use of a nebulizer in the convenience of your own home. While nebulizer care, in the treatment of COPD, has not been as common of a technique in administration, it is expected the approval of the Perforomist Inhaler will change the approach to treatment.

As with most FDA approved prescription medication, the Perforomist Inhaler does not come without side effects and contraindications. For the COPD patient suffering from acute deterioration and complex COPD, the Perforomist Inhaler is not recommended. Additionally, patients who suffer from co-morbid complications of the cardiovascular system should use Perforomist Inhaler with caution and under the strict supervision of a healthcare professional.

Side effects most commonly seen in the COPD patients using the Perforomist Inhaler include diarrhea, dizziness, insomnia and cases of dry mouth, increased thirst and even nasopharyngitis. These symptoms are mild, many COPD sufferers report the benefits of the Perforomist Inhaler far outweigh and potential side effects.